BioSpace News Archive

Business

Hill-Rom Announces Appointment Of Gregory Moore To Board Of Directors

Hill-Rom Holdings, Inc., announced the appointment of Gregory J. Moore MD, PhD, to its Board of Directors, effective May 7, 2019.

May 7, 2019
·
1 min read
Business

Heron Therapeutics Partners with the National Academy of Medicine to Counter the Opioid Epidemic in the United States

Heron Therapeutics, Inc. announced they joined the National Academy of Medicine’s Action Collaborative on Countering the U.S. Opioid Epidemic.

May 7, 2019
·
5 min read
Deals

Infinity Pharmaceuticals Provides Company Update and First Quarter 2019 Financial Results

MARIO-3 Phase 2 Study in Front-Line Triple Negative Breast Cancer and Renal Cell Cancer Patients on Track to Initiate in 3Q19

May 7, 2019
·
8 min read
Business

REGENXBIO Reports First Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD

Continuing subject recruitment for RGX-121 Phase I/II trial for MPS II, RGX-111 Phase I trial for MPS I and RGX-501 Phase I/II trial for HoFH; interim updates for all trials expected in second half 2019

May 7, 2019
·
17 min read
Business

Jazz Pharmaceuticals Announces First Quarter 2019 Financial Results

Received FDA Approval of Sunosi for Excessive Daytime Sleepiness (EDS) Associated with Narcolepsy or Obstructive Sleep Apnea (OSA)

May 7, 2019
·
18 min read
Business

Penumbra, Inc. Reports First Quarter 2019 Financial Results

Penumbra, Inc. reported financial results for the first quarter ended March 31, 2019.

May 7, 2019
·
7 min read
Deals

Varian to Attend Upcoming Investor Events

Varian announced that it will be attending the UBS Global Healthcare Conference and the 2019 RBC Capital Markets Healthcare Conference in New York City.

May 7, 2019
·
1 min read
Deals

Vapotherm Reports First Quarter 2019 Financial Results

Vapotherm, Inc. announced its financial and operating results for the first quarter ended March 31, 2019.

May 7, 2019
·
12 min read
Deals

DLH Reports Second Quarter Fiscal Year 2019 Results

DLH Holdings Corp. announced financial results for its fiscal second quarter ended March 31, 2019.

May 7, 2019
·
8 min read
Genetown

Ironwood Pharmaceuticals to Present at the 2019 Bank of America Merrill Lynch Healthcare Conference

Ironwood Pharmaceuticals, Inc. will present a corporate update at the 2019 Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 14, 2019 at 8:00 a.m. Pacific Time at The Encore Hotel in Las Vegas.

May 7, 2019
·
2 min read